Overview

Prostate Cancer, An Issue of Urologic Clinics

Full Product Details

Author:   Marc A. Bjurlin, DO (Department of Urology<br>NYU School of Medicine) ,  Samir S. Taneja, MD
Publisher:   Elsevier - Health Sciences Division
Imprint:   Elsevier - Health Sciences Division
Volume:   44-4
Weight:   0.540kg
ISBN:  

9780323549059

ISBN 10:   0323549055
Publication Date:   07 November 2017
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   Manufactured on demand  
We will order this item for you from a manufactured on demand supplier.

Table of Contents

Urologic Clinics of North America Prostate Cancer Preface: Prostate Cancer Whom to Biopsy: Prediagnostic Risk Stratification with Biomarkers, Nomograms, and Risk Calculators How to Biopsy: Transperineal Versus Transrectal, Saturation Versus Targeted, What's the Evidence? Prediagnostic Risk Assessment with Prostate MRI and MRI-Targeted Biopsy Whom to Treat: Postdiagnostic Risk Assessment with Gleason Score, Risk Models, and Genomic Classifier Gallium-Prostate-Specific Membrane Antigen PET/Computed Tomography for Primary and Secondary Staging in Prostate Cancer Contemporary Active Surveillance: Candidate Selection, Follow-up Tools, and Expected Outcomes Focal Ablation of Early-Stage Prostate Cancer: Candidate Selection, Treatment Guidance, and Assessment of Outcome Extent of Lymphadenectomy at Time of Prostatectomy: An Evidence-Based Approach Managing Cancer Relapse After Radical Prostatectomy: Adjuvant Versus Salvage Radiation Therapy Newly Diagnosed Metastatic Prostate Cancer: Has the Paradigm Changed? The Role of Local Therapy for Oligometastatic Prostate Cancer: Should We Expect a Cure Approach to the Patient with High-Risk Prostate Cancer Castration-Resistant Prostate Cancer: An Algorithmic Approach

Reviews

Author Information

Dr Taneja's clinical research focuses on the use of imaging to detect and treat prostate cancer. I pioneered the use of MRI to diagnose and pinpoint prostate cancer, and in MRI-guided focal ablative therapies that aim to destroy only the cancerous portion of the prostate. With the ability to precisely locate the cancer, patients no longer need to have the entire gland removed. Through ongoing improvements in imaging and constant integration of new technologies, we continue to evolve this approach to minimize the trauma of prostate cancer surgery. He has authored more than 200 articles, 30 book chapters, and 6 textbooks and monographs on urologic cancer and surgery.

Tab Content 6

Author Website:  

Countries Available

All regions